Dudediligence.

Praxis Precision Medicines, Inc

PRAXNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$11.1M

3 notices · 50,330 sh

Oct 2025 to Oct 2026

Reported ·

$40.7M

16 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 16 reported sales carry the 10b5-1 box. Together they are 1.26% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-06-24: DeSimone Jill, Form 1442025-11-20: Nemiroff Alex, Form 1442025-11-20: Mastrocola Lauren, Form 1442025-10-16: Atchinson Robert, sold2025-11-20: Mastrocola Lauren, sold2025-11-20: Nemiroff Alex, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-06-24DeSimone Jill, Director$3,611,336
11,600 shplan 2026-03-25144 ↗
Form 4, 2026-06-26: sold 11,600 at $311.32 Form 4 ↗
2025-11-20Nemiroff Alex, General Counsel and Secretary$4,852,249
25,130 shno plan date144 ↗
Form 4, 2025-11-21: sold 25,130 at $193.08 Form 4 ↗
2025-11-20Mastrocola Lauren, Principal Accounting Officer$2,612,239
13,600 shno plan date144 ↗
Form 4, 2025-11-21: sold 13,600 at $192.08 Form 4 ↗